Publicly traded company LIXTE Biotechnology will allocate up to 25% of the company's financial reserves to cryptocurrency, pending approval.
BlockBeats News, August 13th, Clinical-stage pharmaceutical company LIXTE Biotechnology Holdings, Inc. (Nasdaq codes: LIXT and LIXTW) announced today that its board of directors has approved a strategic capital allocation plan that will incorporate cryptocurrency into the company's financial reserves. The board has approved allocating up to 25% of the company's financial reserves to cryptocurrency, including Bitcoin and other digital assets as deemed appropriate on a case-by-case basis.
The timing and scale of any such transactions will depend on market conditions at the time and other strategic considerations. LIXTE will continue to closely monitor developments in the digital asset space and retain flexibility to adjust its holdings. The company plans to have all cryptocurrency assets held by fully regulated and compliant custodians. All future transactions will strictly adhere to relevant financial, legal, and auditing regulations to ensure transparency, security, and full regulatory compliance.
You may also like

The U.S. government prohibits foreigners from using Fable 5, Anthropic issues a rebuttal

The other side of Musk's trillion-dollar fortune: 85% cannot be sold

Citibank releases "2030 Asset Tokenization Market Outlook": 6 major trends may create a $8.2 trillion market

The trillion-dollar valuation test: Are the three major super IPOs a celebration for tech stocks or a nightmare for the crypto market?

Morning Report | Digital Asset completes $355 million financing led by a16z Crypto; Meta completes operational separation from Manus

a16z Crypto Partner: Cash flow is the moat

Cryptocurrency market makers collectively seek change as it becomes increasingly difficult to make money

How TradeXYZ, xStocks, and Alpaca break down the SpaceX IPO into three different strategies

$75 billion in risk asset redistribution: How will SpaceX's IPO affect U.S. stocks and Bitcoin?

Why Is BlackRock Investing $5 Billion in the SpaceX IPO?

Morning News | CME Group launches Nasdaq Cryptocurrency Index futures; Asset management giant Janus Henderson strategically invests in Ethena

Bitcoin Layer 2 Network Botanix: Why Did We Choose to Dissolve?

Why did Oracle deliver the strongest financial report in history, yet its stock price fell?

When the P2P illicit funds from ten years ago turned into 60,000 bitcoins

Dialogue with OmenX Founder: Why does the prediction market need an evolution from "spot" to "derivatives"?

Galaxy in-depth report: Is Solana still worth paying attention to?

Young people in South Korea make a "final effort" in the epic bull market

